{
  "architectures": [
    "BertForSequenceClassification"
  ],
  "attention_probs_dropout_prob": 0.1,
  "bos_token_id": 0,
  "classifier_dropout": null,
  "dtype": "float32",
  "eos_token_ids": 0,
  "hidden_act": "gelu",
  "hidden_dropout_prob": 0.1,
  "hidden_size": 1024,
  "id2label": {
    "0": "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING",
    "1": "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES",
    "2": "1.3 CHEMICAL AND PHYSICAL SCIENCES",
    "3": "1.4 METHODOLOGIES AND MEASUREMENTS",
    "4": "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)",
    "5": "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS",
    "6": "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT",
    "7": "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS",
    "8": "2.4 SURVEILLANCE AND DISTRIBUTION",
    "9": "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)",
    "10": "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)",
    "11": "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING",
    "12": "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS",
    "13": "3.3 NUTRITION AND CHEMOPREVENTION",
    "14": "3.4 VACCINES",
    "15": "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)",
    "16": "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES",
    "17": "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES",
    "18": "4.3 INFLUENCES AND IMPACT",
    "19": "4.4 POPULATION SCREENING",
    "20": "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)",
    "21": "5.1 PHARMACEUTICALS",
    "22": "5.2 CELLULAR AND GENE THERAPIES",
    "23": "5.3 MEDICAL DEVICES",
    "24": "5.4 SURGERY",
    "25": "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
    "26": "5.6 PSYCHOLOGICAL AND BEHAVIOURAL",
    "27": "5.7 PHYSICAL",
    "28": "5.8 COMPLEMENTARY",
    "29": "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)",
    "30": "6.1 PHARMACEUTICALS",
    "31": "6.2 CELLULAR AND GENE THERAPIES",
    "32": "6.3 MEDICAL DEVICES",
    "33": "6.4 SURGERY",
    "34": "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
    "35": "6.6 PSYCHOLOGICAL AND BEHAVIOURAL",
    "36": "6.7 PHYSICAL",
    "37": "6.8 COMPLEMENTARY",
    "38": "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)",
    "39": "7.1 INDIVIDUAL CARE NEEDS",
    "40": "7.2 END OF LIFE CARE",
    "41": "7.3 MANAGEMENT AND DECISION MAKING",
    "42": "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)",
    "43": "8.1 ORGANISATION AND DELIVERY OF SERVICES",
    "44": "8.2 HEALTH AND WELFARE ECONOMICS",
    "45": "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE",
    "46": "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)",
    "47": "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)"
  },
  "initializer_range": 0.02,
  "intermediate_size": 4096,
  "label2id": {
    "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING": 0,
    "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES": 1,
    "1.3 CHEMICAL AND PHYSICAL SCIENCES": 2,
    "1.4 METHODOLOGIES AND MEASUREMENTS": 3,
    "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)": 4,
    "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS": 5,
    "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT": 6,
    "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS": 7,
    "2.4 SURVEILLANCE AND DISTRIBUTION": 8,
    "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)": 9,
    "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)": 10,
    "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING": 11,
    "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS": 12,
    "3.3 NUTRITION AND CHEMOPREVENTION": 13,
    "3.4 VACCINES": 14,
    "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)": 15,
    "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES": 16,
    "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES": 17,
    "4.3 INFLUENCES AND IMPACT": 18,
    "4.4 POPULATION SCREENING": 19,
    "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)": 20,
    "5.1 PHARMACEUTICALS": 21,
    "5.2 CELLULAR AND GENE THERAPIES": 22,
    "5.3 MEDICAL DEVICES": 23,
    "5.4 SURGERY": 24,
    "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 25,
    "5.6 PSYCHOLOGICAL AND BEHAVIOURAL": 26,
    "5.7 PHYSICAL": 27,
    "5.8 COMPLEMENTARY": 28,
    "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)": 29,
    "6.1 PHARMACEUTICALS": 30,
    "6.2 CELLULAR AND GENE THERAPIES": 31,
    "6.3 MEDICAL DEVICES": 32,
    "6.4 SURGERY": 33,
    "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 34,
    "6.6 PSYCHOLOGICAL AND BEHAVIOURAL": 35,
    "6.7 PHYSICAL": 36,
    "6.8 COMPLEMENTARY": 37,
    "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)": 38,
    "7.1 INDIVIDUAL CARE NEEDS": 39,
    "7.2 END OF LIFE CARE": 40,
    "7.3 MANAGEMENT AND DECISION MAKING": 41,
    "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)": 42,
    "8.1 ORGANISATION AND DELIVERY OF SERVICES": 43,
    "8.2 HEALTH AND WELFARE ECONOMICS": 44,
    "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE": 45,
    "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)": 46,
    "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)": 47
  },
  "layer_norm_eps": 1e-12,
  "max_position_embeddings": 512,
  "model_type": "bert",
  "num_attention_heads": 16,
  "num_hidden_layers": 24,
  "output_past": true,
  "pad_token_id": 0,
  "position_embedding_type": "absolute",
  "problem_type": "multi_label_classification",
  "transformers_version": "4.57.0",
  "type_vocab_size": 2,
  "use_cache": true,
  "vocab_size": 30522
}